Literature DB >> 6804601

Increased vulnerability of the blood-brain barrier to acute hypertension following depletion of brain noradrenaline.

E Ben-Menachem, B B Johansson, T H Svensson.   

Abstract

Noradrenergic nerve terminals emanating from the pontine nucleus locus coeruleus (LC) have been suggested to take part in the regulation of intracerebral microvascular tone and, hence, blood flow. Since the extent of the blood-brain barrier opening caused by an acute hypertensive reaction previously has been shown to be highly dependent on the pre-existing cerebrovascular tone, we have explored whether selective depletion of brain noradrenaline (NA) would modify the albumin leakage caused by a hypertensive insult in the rat. Brain NA was largely and relatively selectively depleted, particularly in area innervated by the LC, by pretreatment with an injection of 6-hydroxydopamine (6-OHDA, 200 microgram) into the right lateral ventricle 7 days before the induction of an acute hypertensive reaction by intravenously administered angiotensin or adrenaline in conscious, unrestrained rats with indwelling catheters in the aorta and a jugular vein. 6-OHDA pretreatment significantly increased the leakage of 125 I-labelled albumin into the cortex after angiotensin-induced hypertension. A slight non-significant enhancement of protein in extravasation was observed after adrenaline administration. The latter substance caused, however, by itself a larger protein leakage probably related to betareceptor mediated vasodilatation. Whereas the increased permeability induced by adrenaline normally is reduced during the night, the albumin leakage was significantly increased in cortical regions in 6-OHDA treated rats in nocturnal experiments. The enhance protein leakage was not seen in rats treated with desmethylimipramine to prevent the uptake of 6-OHDA into the NA neurons.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6804601     DOI: 10.1007/BF01243407

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  23 in total

1.  In-vivo decarboxylation of alpha-methyl DOPA and alpha-methyl metatyrosine.

Authors:  A CARLSSON; M LINDQVIST
Journal:  Acta Physiol Scand       Date:  1962-01

2.  Sympathetic control of cerebral blood flow in acute arterial hypertension.

Authors:  A Bill; J Linder
Journal:  Acta Physiol Scand       Date:  1976-01

3.  Peripheral sympathetic regulation of brain water permeability.

Authors:  R L Grubb; M E Raichle; J O Eichling
Journal:  Brain Res       Date:  1978-04-07       Impact factor: 3.252

4.  beta-Adrenoreceptor antagonists and the dysfunction of the blood-brain barrier induced by adrenaline.

Authors:  B B Johansson; L Martinsson
Journal:  Brain Res       Date:  1980-01-06       Impact factor: 3.252

5.  Breakthrough of cerebral autoregulation and the sympathetic nervous system.

Authors:  E T MacKenzie; A P McGeorge; D I Graham; W Fitch; L Edvinsson; A M Harper
Journal:  Acta Neurol Scand Suppl       Date:  1977

6.  Blood-brain barrier to albumin in awake rats in acute hypertension induced by adrenaline, noradrenaline or angiotensin.

Authors:  B B Johansson; L Martinsson
Journal:  Acta Neurol Scand       Date:  1979-10       Impact factor: 3.209

Review 7.  The blood-brain barrier in acute and chronic hypertension.

Authors:  B B Johansson
Journal:  Adv Exp Med Biol       Date:  1980       Impact factor: 2.622

8.  The effect of lesions in the locus coeruleus on the physiological responses of the cerebral blood vessels in cats.

Authors:  D Bates; R M Weinshilboum; R J Campbell; T M Sundt
Journal:  Brain Res       Date:  1977-11-18       Impact factor: 3.252

9.  D & L amphetamine stereoisomers: comparative potencies in affecting the firing of central dopaminergic and noradrenergic neurons.

Authors:  B S Bunney; J R Walters; M J Kuhar; R H Roth; G K Aghajanian
Journal:  Psychopharmacol Commun       Date:  1975

10.  Effect of sympathetic stimulation on the blood brain barrier dysfunction induced by amphetamine and by epileptic seizures.

Authors:  B B Johansson; S Lund
Journal:  Acta Physiol Scand       Date:  1978-11
View more
  10 in total

Review 1.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

Review 2.  Blood-brain barrier: structural components and function under physiologic and pathologic conditions.

Authors:  Yuri Persidsky; Servio H Ramirez; James Haorah; Georgette D Kanmogne
Journal:  J Neuroimmune Pharmacol       Date:  2006-07-06       Impact factor: 4.147

Review 3.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 4.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Authors:  Lucy Sanchez-Covarrubias; Lauren M Slosky; Brandon J Thompson; Thomas P Davis; Patrick T Ronaldson
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 5.  Monocyte chemoattractant protein-1 and the blood-brain barrier.

Authors:  Yao Yao; Stella E Tsirka
Journal:  Cell Mol Life Sci       Date:  2013-09-20       Impact factor: 9.261

6.  Cerebrovascular permeability to horseradish peroxidase in hypertensive rats: effects of unilateral locus ceruleus lesion.

Authors:  S Nag; S I Harik
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

7.  Effects of the noradrenaline neurotoxin N-2-chloroethyl-N-ethyl-2-bromo-benzylamine hydrochloride (DSP4) on the blood-brain barrier. An experimental study in the mouse using protein tracer and density determination techniques.

Authors:  C Tengvar; C A Pettersson; A K Mohammed; Y Olsson
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 8.  Age-associated physiological and pathological changes at the blood-brain barrier: A review.

Authors:  Franciska Erdő; László Denes; Elizabeth de Lange
Journal:  J Cereb Blood Flow Metab       Date:  2016-11-11       Impact factor: 6.200

Review 9.  Cell-culture models of the blood-brain barrier.

Authors:  Yarong He; Yao Yao; Stella E Tsirka; Yu Cao
Journal:  Stroke       Date:  2014-06-17       Impact factor: 7.914

Review 10.  Alterations in Expression and Function of ABC Family Transporters at Blood-Brain Barrier under Liver Failure and Their Clinical Significances.

Authors:  Yilin Fan; Xiaodong Liu
Journal:  Pharmaceutics       Date:  2018-07-23       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.